WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 1-Jun.-2018 (data as of 25-May-2018)
Next overall update Mid-July 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'5401 Infant (under 12 months) mortality rate: 392
GDP / capita (US$): 6'3681 Child (under 5 years) mortality rate: 542

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 5'261  5'126  4'996  4'871  4'751  3'226  2'440  1'840 
Births 180  178  176  175  173  127  94  78 
Surviving infants 173  171  169  167  165  116  86  71 
Pop. less than 5 years 833  824  814  802  789  527  403  330 
Pop. less than 15 years 2'224  2'172  2'120  2'065  2'010  1'340  1'065  826 
Female 15-49 years 1'238  1'206  1'177  1'151  1'127  774  554  403 

Number of reported cases

(Click for retrospective incidence data for Congo (the))
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  958  277  1'359  71  124  1'678  3'608  11'892 
Mumps
ChartChart
 
Pertussis
ChartChart
  21  137  52  11'198 
Polio*
ChartChart
  47  136 
Rubella
ChartChart
  12  45  107 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  18  80 
Tetanus (total)**
ChartChart
  14  27  167 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Congo (the))
Vaccine year result method % card seen                                                
BCG 2013  92  MICS   50  90  82  85  95  92  50  86 
DTP1 2013  87  MICS   50  80  78  85  95  90 
DTP3 2013  67  MICS   50  80  73  80  90  85  33  77 
DTP4         
IPV1          80  37 
HepB_BD         
HepB3 2013  57  MICS   50  80  73  80  90  85 
Hib3 2013  58  MICS   50  80  73  80  90  85 
JapEnc         
MCV1          80  69  80  80  80  34  77 
MCV2         
MenA         
PCV1          80  75  85  90  90 
PCV2          80  69  85  90  85 
PCV3          80  73  80  85  85 
Pol3 2013  47  MICS   50  80  73  80  90  85  94 
Rota1          80  72  80  70 
RotaC          80  66  80  60 
RCV1         
TT2plus 2013  59  MICS   50  90  73  85  90  85  39  52 
PAB         
VAD1          80  69  80  80  86 
YFV 2013  54  MICS   50  80  69  80  80  80 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Congo (the))
BCG
ChartChart
  85  85  95  92  50  90  92 
DTP1
ChartChart
  85  85  95  90  45  92  67 
DTP3
ChartChart
  80  80  90  85  33  79  42 
HepB3
ChartChart
  80  80  90  85 
HepB_BD
 
Hib3
ChartChart
  80  80  90  85 
IPV1
 
MCV1
ChartChart
  80  80  80  80  34  75  49 
MCV2
 
PCV3
ChartChart
  80  80  85  85 
Pol3
ChartChart
  80  80  90  85  31  80  42 
RCV1
 
RotaC
ChartChart
  80  80  60 
YFV
ChartChart
  65  65  65  65 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 41  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 10
From 80 to 89% 15
From 50 to 79% 51
Less than 50% 24
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 8, 12, 16 weeks; Yes
IPV 16 weeks; Yes
Measles 36 weeks; Yes
MR From July 2018
OPV birth; 8, 12, 16 weeks; Yes
Pneumo_conj 8, 12, 16 weeks; Yes
Rotavirus 8, 12 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 years; Yes Pregnant women
VitaminA 36 weeks; Yes
YF 36 weeks; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2018-2022  2012-2016  2012-2016  2012-2016  2012-2016  2012-2016  2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 41  41  15  17  30  30  30 

System performance

Total Nº districts in country number 41  41  30  30  30  30  30 
Nº districts with DTP3 coverage >=80% number 10  12  11  23  22  21  22 
% of districts with DTP3 coverage >=80% From 0 to 100% 24  29  37  77  73  70  73 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 10  13  20  10  13  23 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  No  No  No  No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 20  38  39  40  24  28  30 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.